Brivaracetam Impurity 87 CAS CATO-C4X-200787

Purity 97%+In StockPharmacopoeial Impurity Standards
CAS No.CATO-C4X-200787
Molecular FormulaC11H22O3
Molecular Weight202.29 g/mol
CategoryPharmacopoeial Impurity Standards / EP Impurities
AvailabilityIn Stock

Chemical Structure

Brivaracetam Impurity 87 CAS CATO-C4X-200787 chemical structure

Description

Compared with other compounds in its class, the molecular weight of 202.29 g/mol gives Brivaracetam Impurity 87 distinctive chromatographic separation conditions and mass-spectrometry parameter settings.

As a process- or degradation-related impurity, Brivaracetam Impurity 87 (CAS CATO-C4X-200787, C11H22O3) is essential for impurity profiling, related-substances testing, and forced-degradation studies in pharmaceutical development.

Brivaracetam Impurity 87 (C11H22O3) contains a carboxylic acid group, a hydroxyl group, an ether linkage. It is notably hygroscopic, its high carbon-to-hydrogen ratio confers good lipid solubility, the carboxyl group imparts weak acidity; these physicochemical properties determine the optimal preparation and storage of its standard solutions. The high carbon-to-hydrogen ratio imparts good lipophilicity, allowing liquid-liquid extraction with non-polar solvents such as n-hexane or ethyl acetate.

This reference standard supports related-substances testing and method development in line with ICH Q3A/Q3B guidance on impurity control, and is suitable for system suitability testing and forced-degradation studies.

CATO manufactures Brivaracetam Impurity 87 under ISO 17034:2016 accreditation with dual CNAS and ANAB accreditation. Each batch is characterized by orthogonal methods and supplied with a full Certificate of Analysis (COA), ensuring metrological traceability.

Physical & Chemical Properties

Molecular FormulaC11H22O3
Molecular Weight202.29 g/mol
Purity97%+
StorageStore in a cool place (≤25°C), keep sealed and dry
Solubility (reference)Soluble in methanol, ethanol, DMSO
StabilityHygroscopic; reseal immediately after opening
Degree of Unsaturation (DBE)1.0

Related Brivaracetam Standards

Recommended Standards

Why CATO?